Search

Your search keyword '"Shah, Sohrab P."' showing total 150 results

Search Constraints

Start Over You searched for: Author "Shah, Sohrab P." Remove constraint Author: "Shah, Sohrab P." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
150 results on '"Shah, Sohrab P."'

Search Results

1. Cancer phylogenetic tree inference at scale from 1000s of single cell genomes

2. Transformer-based segmentation of adnexal lesions and ovarian implants in CT images

4. DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism

5. Single-cell mtDNA dynamics in tumors is driven by coregulation of nuclear and mitochondrial genomes

7. Epigenetic dysregulation from chromosomal transit in micronuclei.

11. Ovarian cancer mutational processes drive site-specific immune evasion

12. Single-cell genomic variation induced by mutational processes in cancer

13. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

14. Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer

16. Fundamental immune–oncogenicity trade-offs define driver mutation fitness

17. Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer

19. Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer

20. Accurate determination of CRISPR-mediated gene fitness in transplantable tumours

21. Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk

24. Multimodal histopathologic models stratify hormone receptor-positive early breast cancer

25. FIGURE 4 from Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 Expression

26. Weakly supervised deep learning predicts immunotherapy response in solid tumors based on PD-L1 expression

27. Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma

28. Author Correction: Fundamental immune–oncogenicity trade-offs define driver mutation fitness

29. Abstract 102: Transient chromosomal instability as a driver of ovarian cancer genome evolution

31. Chafe et al Supplementary Materials and Methods from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically

32. Abstract 5721: Automated annotation for large-scale clinicogenomic models of lung cancer treatment response and overall survival

33. Abstract 4259: Identification of anti-neoplastic therapy given before initial visit at a referral center using natural language processing applied to medical oncology initial consultation notes

34. Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically

35. Abstract 3142: Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology

36. Chafe et al Supplementary Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically

37. Supplementary Table S11 and 15 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

38. Supplementary Table S1-3 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

39. Supplementary Data from Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

40. Supplementary Table S8-9 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

41. Supplementary Table S12-14 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

42. Data from Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

43. Supplementary Methods and Figures from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

44. Supplementary Table S10 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

45. Supplementary Table 1 from Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001

46. Supplementary Table 2 from Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001

47. Supplementary Table 1 from Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis

48. Data from Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis

49. Signatures of Immune Evasion in Pediatric Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

50. Transforming ovarian cancer care by targeting minimal residual disease

Catalog

Books, media, physical & digital resources